- Report
- October 2025
- 81 Pages
Saudi Arabia
From €4231EUR$4,850USD£3,684GBP
From €4231EUR$4,850USD£3,684GBP
- Report
- October 2025
- 80 Pages
Saudi Arabia
From €4231EUR$4,850USD£3,684GBP
- Report
- October 2025
- 98 Pages
Singapore
From €4231EUR$4,850USD£3,684GBP
- Report
- September 2025
- 97 Pages
Italy
From €4231EUR$4,850USD£3,684GBP
- Report
- October 2025
- 88 Pages
Philippines
From €4231EUR$4,850USD£3,684GBP
- Report
- October 2025
- 86 Pages
Saudi Arabia
From €4231EUR$4,850USD£3,684GBP
- Report
- October 2025
- 82 Pages
Saudi Arabia
From €4231EUR$4,850USD£3,684GBP
- Report
- October 2025
- 96 Pages
Japan
From €4231EUR$4,850USD£3,684GBP
- Report
- September 2025
- 88 Pages
United Kingdom
From €4231EUR$4,850USD£3,684GBP
- Training
- April 2025
- 1 Day
Global
From €749EUR$859USD£652GBP
- Report
- December 2024
- 96 Pages
Global
From €3999EUR$4,911USD£3,605GBP
- Report
- January 2024
- 48 Pages
India
- Database
- July 2023
Global
From €314EUR$360USD£273GBP
- Report
- June 2023
Global
From €1308EUR$1,500USD£1,140GBP
- Report
- April 2022
Global
€8723EUR$10,000USD£7,597GBP
- Report
- October 2022
- 307 Pages
Global
From €2181EUR$2,500USD£1,899GBP
- Report
- January 2024
- 124 Pages
Global
From €3500EUR$4,298USD£3,155GBP
- Report
- December 2024
- 150 Pages
Global
From €3446EUR$3,950USD£3,001GBP
- Report
- May 2023
- 80 Pages
Russia
From €1308EUR$1,500USD£1,140GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more